Finance

Beta
Lists
PBLS:NASDAQ
Parabilis Medicines Inc
$29.06
-2.84%
(-0.85) 1D
$29.06
0.00% (0.00)
After hours
Closed: Jul 16, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PBLS...
Open
$29.79
High
$30.59
Low
$28.57
Mkt. cap
3.39B
Avg. vol.
835.35K
Volume
520.58K
52-wk high
$34.47
52-wk low
$24.66
EPS
-$1.77
No. of employees
145
Open
$29.79
High
$30.59
Low
$28.57
Mkt. cap
3.39B
Avg. vol.
835.35K
Volume
520.58K
52-wk high
$34.47
52-wk low
$24.66
EPS
-$1.77
No. of employees
145
News stories
From sources across the web
About Parabilis Medicines Inc
CEO-
Employees145
Founded2015
Headquarters-
SectorBiotechnology
Websiteparabilismed.com
Analyst ratings
Based on 5 analysts giving stock ratings to PBLS in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PBLS in the last 3 months.
Highest
Current $29.06
$45.00 (+54.85%)
Average
$41.75 (+43.67%)
Lowest
$40.00 (+37.65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Charles Zhu
LifeSci Capital
Buy
Maintained
$42.00
+44.5%
07/11/2026
Andrew Berens
Leerink Partners
Buy
Initiated
$40.00
+37.6%
07/06/2026
Umer Raffat
Evercore ISI
Buy
Initiated
-
-
07/06/2026
Tazeen Ahmad
Bank of America Securities
Buy
Initiated
$45.00
+54.9%
07/06/2026
Michael Schmidt
Guggenheim
Buy
Initiated
$40.00
+37.6%
07/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
33.90M
37.75M
Total research and development expenses
-
-
Selling, general, and admin expenses
5.28M
9.70M
Operating expense
39.18M
47.45M
Total operating expenses
39.18M
47.45M
Operating income
-39.18M
-47.45M
Other non operating income
-
-
EBT including unusual items
-38.33M
-45.32M
EBT excluding unusual items
-38.33M
-45.32M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-38.33M
-45.32M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
1.26M
2.43M
Interest expense
-399.00K
-292.00K
Net interest expenses
858.00K
2.14M
Depreciation and amortization charges
-
-
EBITDA
-38.53M
-46.85M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer